1-11 of 11
Bart Keymeulen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study

Sara Charleer, Christophe De Block, Frank Nobels, Régis P. Radermecker, Ine Lowyck, Annelies Mullens, Denis Scarnière, Katrien Spincemaille, Marie Strivay, Eric Weber, Youri Taes, Chris Vercammen, Bart Keymeulen, Chantal Mathieu, Pieter Gillard
Journal: Diabetes Care
Diabetes Care 2020;43(12):3016–3023
https://doi.org/10.2337/dc20-1531
Published: 16 October 2020
View article titled, Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study
Open the PDF for Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study in another window
Journal Articles

Accelerated Progression to Type 1 Diabetes in the Presence of HLA-A*24 and -B*18 Is Restricted to Multiple Islet Autoantibody–Positive Individuals With Distinct HLA-DQ and Autoantibody Risk Profiles

Else M. Balke, Eric V. Balti, Bart Van der Auwera, Ilse Weets, Olivier Costa, Simke Demeester, Pascale Abrams, Kristina Casteels, Marina Coeckelberghs, Sylvie Tenoutasse, Bart Keymeulen, Daniel G. Pipeleers, Frans K. Gorus, the Belgian Diabetes Registry
Journal: Diabetes Care
Diabetes Care 2018;41(5):1076–1083
https://doi.org/10.2337/dc17-2462
Published: 15 March 2018
View article titled, Accelerated Progression to Type 1 Diabetes in the Presence of <em>HLA-A*24</em> and <em>-B*18</em> Is Restricted to Multiple Islet Autoantibody–Positive Individuals With Distinct <em>HLA-DQ</em> and Autoantibody Risk Profiles
Open the PDF for Accelerated Progression to Type 1 Diabetes in the Presence of <em>HLA-A*24</em> and <em>-B*18</em> Is Restricted to Multiple Islet Autoantibody–Positive Individuals With Distinct <em>HLA-DQ</em> and Autoantibody Risk Profiles in another window
Includes: Supplementary data
Journal Articles

Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes

Frans K. Gorus, Eric V. Balti, Anissa Messaaoui, Simke Demeester, Annelien Van Dalem, Olivier Costa, Harry Dorchy, Chantal Mathieu, Luc Van Gaal, Bart Keymeulen, Daniël G. Pipeleers, Ilse Weets, for the Belgian Diabetes Registry
Journal: Diabetes Care
Diabetes Care 2017;40(8):1065–1072
https://doi.org/10.2337/dc16-2228
Published: 11 July 2017
View article titled, Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and <em>HLA-DQ</em> Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes
Open the PDF for Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and <em>HLA-DQ</em> Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

HLA-A*24 Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet Allograft

Simke Demeester, Else M. Balke, Bart J. Van der Auwera, Pieter Gillard, Robert Hilbrands, DaHae Lee, Ursule Van de Velde, Zhidong Ling, Bart O. Roep, Daniel G. Pipeleers, Frans K. Gorus, Bart Keymeulen
Journal: Diabetes Care
Diabetes Care 2016;39(6):1060–1064
https://doi.org/10.2337/dc15-2768
Published: 26 April 2016
View article titled, <em>HLA-A*24</em> Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet Allograft
Open the PDF for <em>HLA-A*24</em> Carrier Status and Autoantibody Surges Posttransplantation Associate With Poor Functional Outcome in Recipients of an Islet Allograft in another window
Includes: Supplementary data
Journal Articles

Evidence-Informed Clinical Practice Recommendations for Treatment of Type 1 Diabetes Complicated by Problematic Hypoglycemia

Pratik Choudhary, Michael R. Rickels, Peter A. Senior, Marie-Christine Vantyghem, Paola Maffi, Thomas W. Kay, Bart Keymeulen, Nobuya Inagaki, Frantisek Saudek, Roger Lehmann, Bernhard J. Hering
Journal: Diabetes Care
Diabetes Care 2015;38(6):1016–1029
https://doi.org/10.2337/dc15-0090
Published: 12 May 2015
View article titled, Evidence-Informed Clinical Practice Recommendations for Treatment of Type 1 Diabetes Complicated by Problematic Hypoglycemia
Open the PDF for Evidence-Informed Clinical Practice Recommendations for Treatment of Type 1 Diabetes Complicated by Problematic Hypoglycemia in another window
Journal Articles

Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes

Simke Demeester, Bart Keymeulen, Leonard Kaufman, Annelien Van Dalem, Eric V. Balti, Ursule Van de Velde, Patrick Goubert, Katrijn Verhaeghen, Howard W. Davidson, Janet M. Wenzlau, Ilse Weets, Daniel G. Pipeleers, Frans K. Gorus
Journal: Diabetes Care
Diabetes Care 2015;38(4):644–651
https://doi.org/10.2337/dc14-1575
Published: 12 January 2015
View article titled, Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes
Open the PDF for Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients

Pieter Gillard, MD, Robert Hilbrands, MD, Ursule Van de Velde, MSCN, Zhidong Ling, MD, Da Hae Lee, MD, Ilse Weets, MD, Frans Gorus, MD, Christophe De Block, MD, Leonard Kaufman, PHD, Chantal Mathieu, MD, Daniel Pipeleers, MD, Bart Keymeulen, MD
Journal: Diabetes Care
Diabetes Care 2013;36(11):3483–3488
https://doi.org/10.2337/dc13-0128
Published: 15 October 2013
View article titled, Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients
Open the PDF for Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients in another window
Includes: Supplementary data
Journal Articles

Contribution of Antibodies Against IA-2β and Zinc Transporter 8 to Classification of Diabetes Diagnosed Under 40 Years of Age

Ilse Vermeulen, IR, Ilse Weets, MD, Milca Asanghanwa, MSC, Johannes Ruige, MD, Luc Van Gaal, MD, Chantal Mathieu, MD, Bart Keymeulen, MD, Vito Lampasona, PHD, Janet M. Wenzlau, PHD, John C. Hutton, PHD, Daniel G. Pipeleers, MD, Frans K. Gorus, MD, The Belgian Diabetes Registry
Journal: Diabetes Care
Diabetes Care 2011;34(8):1760–1765
https://doi.org/10.2337/dc10-2268
Published: 16 July 2011
View article titled, Contribution of Antibodies Against IA-2β and Zinc Transporter 8 to Classification of Diabetes Diagnosed Under 40 Years of Age
Open the PDF for Contribution of Antibodies Against IA-2β and Zinc Transporter 8 to Classification of Diabetes Diagnosed Under 40 Years of Age in another window
Includes: Supplementary data
Journal Articles

Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies

Pieter Gillard, MD, PHD, Volkert Huurman, MD, PHD, Bart Van der Auwera, PHD, Brigitte Decallonne, MD, PHD, Kris Poppe, MD, PHD, Bart O. Roep, PHD, Frans Gorus, MD, PHD, Chantal Mathieu, MD, PHD, Daniel Pipeleers, MD, PHD, Bart Keymeulen, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(10):1817–1819
https://doi.org/10.2337/dc08-2339
Published: 23 June 2009
View article titled, Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies
Open the PDF for Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies in another window
Journal Articles

β-Cell Transplantation Restores Metabolic Control and Quality of Life in a Patient With Subcutaneous Insulin Resistance

Pieter Gillard, MD, Zhidong Ling, MD, PHD, Matthias Lannoo, MD, Bart Maes, MD, PHD, Geert Maleux, MD, Daniel Pipeleers, MD, PHD, Bart Keymeulen, MD, PHD, Chantal Mathieu, MD, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(9):2243–2244
https://doi.org/10.2337/diacare.27.9.2243
Published: 01 September 2004
View article titled, β-Cell Transplantation Restores Metabolic Control and Quality of Life in a Patient With Subcutaneous Insulin Resistance
Open the PDF for β-Cell Transplantation Restores Metabolic Control and Quality of Life in a Patient With Subcutaneous Insulin Resistance in another window
Journal Articles

The Incidence of Type 1 Diabetes in the Age Group 0–39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000: Evidence for earlier disease manifestation

Ilse Weets, MD, Ivo H. De Leeuw, MD, PHD, Marc V.L. Du Caju, MD, PHD, Raoul Rooman, MD, Bart Keymeulen, MD, PHD, Chantal Mathieu, MD, PHD, Raoul Rottiers, MD, Jean-Claude Daubresse, MD, Danielle Rocour-Brumioul, MD, Daniel G. Pipeleers, MD, PHD, Frans K. Gorus, MD, PHD, The Belgian Diabetes Registry
Journal: Diabetes Care
Diabetes Care 2002;25(5):840–846
https://doi.org/10.2337/diacare.25.5.840
Published: 01 May 2002
View article titled, The Incidence of Type 1 Diabetes in the Age Group 0–39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000: <subtitle>Evidence for earlier disease manifestation</subtitle>
Open the PDF for The Incidence of Type 1 Diabetes in the Age Group 0–39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000: <subtitle>Evidence for earlier disease manifestation</subtitle> in another window